{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Franklin Lakes",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "91495",
      "recalling_firm": "Becton Dickinson & Company",
      "address_1": "1 Becton Dr",
      "address_2": "N/A",
      "postal_code": "07417-1815",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.",
      "recall_number": "Z-1240-2023",
      "product_description": "BD Ultra-Fine Insulin Syringe 0.5mL, 8mm, 31G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus.  Catalog Number: 326713",
      "product_quantity": "1,129,000 units",
      "reason_for_recall": "Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.",
      "recall_initiation_date": "20230201",
      "center_classification_date": "20230310",
      "report_date": "20230322",
      "code_info": "GTIN: N/A Lot Number: 2038580, Exp. Date: 20270531; Lot Number: 2063298, Exp. Date: 20270531; Lot Number: 2137904, Exp. Date: 20270731"
    }
  ]
}